hetacillin
{{Short description|Chemical compound}}
{{Use dmy dates|date=September 2024}}
{{cs1 config |name-list-style=vanc |display-authors=6}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 461767356
| IUPAC_name = (2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
| image = Hetacillin structure.svg
| tradename = Hetacin, Versapen
| Drugs.com = {{Drugs.com|vet|hetacin-k-intramammary-infusion}}
| pregnancy_AU =
| pregnancy_category =
| routes_of_administration = Intramammary injection
| ATC_prefix = J01
| ATC_suffix = CA18
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US = Rx-only
| legal_status =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3511-16-8
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00739
| PubChem = 443387
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 391616
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TN4JSC48CV
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D01074
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201116
| chemical_formula =
| C=19 | H=23 | N=3 | O=4 | S=1
| smiles = CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N3C(=O)[C@H](NC3(C)C)c4ccccc4)C(=O)O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C19H23N3O4S/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10/h5-9,11-13,16,20H,1-4H3,(H,25,26)/t11-,12-,13+,16-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = DXVUYOAEDJXBPY-NFFDBFGFSA-N
}}
Hetacillin is a beta-lactam antibiotic that is part of the aminopenicillin family. It is a prodrug and has no antibacterial activity itself,{{cite web | work = Drugbank | url = http://www.drugbank.ca/drugs/DB00739 | title = Hetacillin }} but quickly splits off acetone in the human body to form ampicillin,{{cite journal | vauthors = Sutherland R, Robinson OP | title = Laboratory and pharmacological studies in man with hetacillin and ampicillin | journal = British Medical Journal | volume = 2 | issue = 5555 | pages = 804–8 | date = June 1967 | pmid = 5182358 | pmc = 1843140 | doi = 10.1136/bmj.2.5555.804 }} which is active against a variety of bacteria.
__TOC__
Administration
Hetacillin can be administered orally. The potassium salt, hetacillin potassium, is administered by injection, either intravenously{{cite journal | vauthors = Tsuji Y, Tomita M | title = [Clinical effect of intravenous injection of potassium hetacillin (Versapen 'Bristol') on pre- and post-operative infections] (in Japanese) | journal = The Japanese Journal of Antibiotics | volume = 23 | issue = 4 | pages = 400–2 | date = August 1970 | pmid = 5312791 }} or intramuscularly.{{cite journal | vauthors = Hara M, Takemoto S, Kawazu T | title = [Therapeutic experience with intramuscular injection of hetacillin (Versapen 'Bristol') in infection in children] (in Japanese) | journal = The Japanese Journal of Antibiotics | volume = 23 | issue = 5 | pages = 482–6 | date = December 1970 | pmid = 5314634 }} It is sold under the trade name Hetacin for intramammary injection in veterinary use.Hetacin-K Intramammary Infusion for {{Drugs.com|vet|hetacin-k-intramammary-infusion}}
Hetacillin was withdrawn from the market for human use when the discovery was made that it had no advantages over ampicillin.{{cite journal | vauthors = Smith JT, Hamilton-Miller J | title = Hetacillin: A Chemical and Biological Comparison with Ampicillin | journal = Chemotherapy | volume = 15 | issue = 6 | pages = 366–78 | year = 1970 | pmid = 5514976 | doi = 10.1159/000220703 }}
Chemistry
Hetacillin is prepared from ampicillin and acetone. In aqueous solutions it is unstable, with a half life of 15 to 30 minutes at {{convert|37|°C|°F}} and pH 7, quickly releasing acetone again.{{cite journal | vauthors = Faine S, Harper M | title = Independent antibiotic actions of hetacillin and ampicillin revealed by fast methods | journal = Antimicrobial Agents and Chemotherapy | volume = 3 | issue = 1 | pages = 15–8 | date = January 1973 | pmid = 4597707 | pmc = 444353 | doi = 10.1128/aac.3.1.15 }}
References
{{reflist}}
{{Cell wall disruptive antibiotics}}
{{Xenobiotic-sensing receptor modulators}}
{{Portal bar | Medicine}}
{{Authority control}}